![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Techno Trends
Oral therapy with Teriflunomide reduces relapses in multiple sclerosis
Sanofi and its subsidiary Genzyme has announced new data from the TEriflunomide multiple sclerosis oral (TEMSO) phase III trial showing once-daily oral teriflunomide significantly...
Techno Trends
CRANE ChemPharma Flow Solutions Launches New Interactive BioPharm Applications Module
CRANE ChemPharma Flow Solutions announced the launch of its new BioPharm applications module, an addition to its existing www.cranechempharma.com website. Â The new interactive...
Techno Trends
Novel Hepatitis C Vaccine First Effective Way
French scientists have developed a novel hepatitis C vaccine that may offer the first effective way to prevent an infection that can cause chronic...
Techno Trends
Oracle Introduces Oracle Health Sciences InForm Global Trial Management 5.5
Oracle Health Sciences announced the availability of Oracle Health Sciences InForm Global Trial Management (GTM) 5.5, which includes powerful new functionality to help trial...
Techno Trends
U.S. Southeast ‘Stroke Belt’ Also Shows Higher Rates of Cognitive Decline
People living in an area of the southeastern United States known as the "Stroke Belt" are also at greater risk for cognitive decline, or...
Techno Trends
Omega-3 Fatty Acids Help Heart Patients With Stents
Combining omega-3 fatty acids with blood-thinning drugs may reduce the risk of heart attacks in patients who've had stents placed in their coronary arteries,...
Techno Trends
Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today unveiled its enhanced next-generation albumin technology, which was developed in collaboration with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read